Teresa Capursi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Teresa Capursi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Maria Elisabetta Baldassarre
Department of Interdisciplinary Medicine, Neonatology and NICU, Aldo Moro University, 70121 Bari, Italy
3 shared publications - Nicola Laforgia
Section of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, “Aldo Moro” University of Bari, 70121 Bari, Italy
2 shared publications Adolfo Cella
Neonatology and NICU,Azienda Ospedaliero- Universitaria Ospedali Riuniti - Foggia
1 shared publicationAlexander Padovano
Washington University, St. Louis, MO, USA
1 shared publicationAlfredo Miccheli
Department of Chemistry, Sapienza University, Piazzale Aldo Moro 5, I-00185 Rome, Italy
1 shared publicationAnna Lobascio
Second Department of Obstetrics and Gynaecology, University of Bari, Policlinico, 70124-Bari, Italy
1 shared publication
Latest Publications
- 26 April 2012
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 34 (6) , 932-936
Usefulness of tissue transglutaminase type 2 antibodies in early pregnancy
Celiac disease (CD), an autoimmune disease triggered by dietary gluten, is a multi-systemic disorder that primarily results in mucosal damage of the small intestine. Reproductive disorders and pregnancy complications have been associated with CD. Conflicting results have been published concerning CD and the risk of impaired fetal growth with reduced birthweight. The aim of our multicentric, perspective, case–control study was to determine the prevalence of undiagnosed CD in mothers of small for gestational age (SGA) newborns in two regions of Italy. The study included 480 mothers: group A consisted of 284 SGA newborns’ mothers and group B consisted of 196 appropriate for gestational age (AGA) newborns’ mothers. Tissue transglutaminase type 2 antibodies (TG2) IgA and IgG were measured in blood samples. We diagnosed two new cases of CD in asymptomatic mothers. It may be appropriate to include the TG2 to the panel of prenatal blood test.
- 26 April 2012
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 34 (6) , 932-936
Usefulness of tissue transglutaminase type 2 antibodies in early pregnancy
Celiac disease (CD), an autoimmune disease triggered by dietary gluten, is a multi-systemic disorder that primarily results in mucosal damage of the small intestine. Reproductive disorders and pregnancy complications have been associated with CD. Conflicting results have been published concerning CD and the risk of impaired fetal growth with reduced birthweight. The aim of our multicentric, perspective, case–control study was to determine the prevalence of undiagnosed CD in mothers of small for gestational age (SGA) newborns in two regions of Italy. The study included 480 mothers: group A consisted of 284 SGA newborns’ mothers and group B consisted of 196 appropriate for gestational age (AGA) newborns’ mothers. Tissue transglutaminase type 2 antibodies (TG2) IgA and IgG were measured in blood samples. We diagnosed two new cases of CD in asymptomatic mothers. It may be appropriate to include the TG2 to the panel of prenatal blood test.
- Open Access
- 1 January 2012
- Published by Springer Nature in BMC Microbiology
- Vol. 12 (1) , 236
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion
The vaginal microbiota of healthy women consists of a wide variety of anaerobic and aerobic bacterial genera and species dominated by the genus Lactobacillus. The activity of lactobacilli helps to maintain the natural healthy balance of the vaginal microbiota. This role is particularly important during pregnancy because vaginal dismicrobism is one of the most important mechanisms for preterm birth and perinatal complications. In the present study, we characterized the impact of a dietary supplementation with the probiotic VSL#3, a mixture of Lactobacillus, Bifidobacterium and Streptococcus strains, on the vaginal microbiota and immunological profiles of healthy women during late pregnancy.
- 1 January 2012
- Published by Springer Nature in BMC Microbiology
- Vol. 12 (1) , 236
Open AccessDietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion
The vaginal microbiota of healthy women consists of a wide variety of anaerobic and aerobic bacterial genera and species dominated by the genus Lactobacillus. The activity of lactobacilli helps to maintain the natural healthy balance of the vaginal microbiota. This role is particularly important during pregnancy because vaginal dismicrobism is one of the most important mechanisms for preterm birth and perinatal complications. In the present study, we characterized the impact of a dietary supplementation with the probiotic VSL#3, a mixture of Lactobacillus, Bifidobacterium and Streptococcus strains, on the vaginal microbiota and immunological profiles of healthy women during late pregnancy.
- 1 January 1994
- Vol. 15 (3) , 222-9
Expression of AgNORs in serous ovarian tumors.
The nosological nature of the borderline ovarian tumor has been investigated by several methodological approaches. The aim of our research was to verify how the study of the nucleolar organizer regions (AgNOR) may offer its contribution on this subject. We studied 18 cases of ovarian serous tumours, respectively 6 benign, 6 borderline and 6 malignant. A separate calculation for clusters (> 1 mu) and total NORs was performed on fifty neoplastic cells chosen at random from every tumour. The findings recorded were the following: 1) the quantity and shape of clusters, dots and total NORs were significantly increasing from benign to borderline to malignant tumours; 2) the number of the dots and total NORs was higher in the case of borderline tumour stage III than in other cases limited to the ovary; 3) the clusters of the poorly differentiated carcinomas were much less numerous than the clusters of those well differentiated; instead the dots and the total NORs were more numerous. These data suggest a correlation between the number of the NORs and the biological activity of the tumours. The borderline serous tumours of the ovary showed a median position between benign and malignant tumours.
- 1 January 1994
- Vol. 15 (3) , 222-9
Expression of AgNORs in serous ovarian tumors.
The nosological nature of the borderline ovarian tumor has been investigated by several methodological approaches. The aim of our research was to verify how the study of the nucleolar organizer regions (AgNOR) may offer its contribution on this subject. We studied 18 cases of ovarian serous tumours, respectively 6 benign, 6 borderline and 6 malignant. A separate calculation for clusters (> 1 mu) and total NORs was performed on fifty neoplastic cells chosen at random from every tumour. The findings recorded were the following: 1) the quantity and shape of clusters, dots and total NORs were significantly increasing from benign to borderline to malignant tumours; 2) the number of the dots and total NORs was higher in the case of borderline tumour stage III than in other cases limited to the ovary; 3) the clusters of the poorly differentiated carcinomas were much less numerous than the clusters of those well differentiated; instead the dots and the total NORs were more numerous. These data suggest a correlation between the number of the NORs and the biological activity of the tumours. The borderline serous tumours of the ovary showed a median position between benign and malignant tumours.
- 1 December 1993
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 52 (3) , 229-231
Ultrasound diagnosis of heterotopic pregnancy with viable fetuses
- 1 December 1993
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 52 (3) , 229-231
Ultrasound diagnosis of heterotopic pregnancy with viable fetuses